tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Lifeward Ltd. Reports Q2 2025 Financial Results

Lifeward Ltd. Reports Q2 2025 Financial Results

Rewalk Robotics Ltd. ( (LFWD) ) has released its Q2 earnings. Here is a breakdown of the information Rewalk Robotics Ltd. presented to its investors.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Lifeward Ltd., a global leader in innovative medical technology, specializes in developing solutions for individuals with physical limitations, offering products like the ReWalk Exoskeleton and AlterG Anti-Gravity system. In its second quarter of 2025 financial results, Lifeward reported significant achievements, including a record number of ReWalk systems placed for Medicare beneficiaries and the appointment of new CEO and CFO to drive strategic change. The company achieved FDA clearance for the ReWalk 7 and expanded its U.S. payer base, reflecting positive market reception and strategic partnerships. Financially, Lifeward’s revenue decreased by 15% compared to the previous year, primarily due to the absence of one-time Medicare-related revenue, although operational efficiencies led to improved cash burn and gross margins. Despite a net loss of $6.6 million, Lifeward’s management remains optimistic, focusing on operational efficiencies and strategic growth initiatives to achieve its financial guidance for 2025.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1